SCHEMBL4428027

SCHEMBL4428027

COc1cccc(C(CCc2ccc(C(F)(F)F)cc2)N[S+]([O-])C(C)(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 7/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
OPRK1 P41145 1/20 0.42
TACR1 P25103 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
FFAR2 O15552 1/20 0.37
CCR3 P51677 1/20 0.37
TMEM97 Q5BJF2 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
UTS2R Q9UKP6 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4440361 0.88 MEN1 (0.53) MEN1KMT2ASMN1; SMN2POLBHTT
SCHEMBL4429764 0.85 CASR (0.41) CASRMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2320170 0.81 CCR3 (0.42) MEN1KMT2AOPRK1LMNAHTT
SCHEMBL4435446 0.79 MEN1 (0.39) CASRMEN1KMT2ATMEM97
SCHEMBL4428090 0.79 KCNH2 (0.41) CASRMEN1KMT2ACCR3TMEM97
SCHEMBL8163235 0.79 KCNH2 (0.51) MEN1KMT2ATMEM97UTS2R
SCHEMBL4927218 0.78 AOC3 (0.43) CASROPRK1TMEM97
SCHEMBL3739840 0.77 CASR (0.50) CASRMEN1KMT2AOPRK1TACR1
SCHEMBL4432287 0.77 KMT2A (0.49) MEN1KMT2ASMN1; SMN2LMNAPOLB
SCHEMBL22556982 0.74 AOC3 (0.39) CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed